Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	TNRC6B NBN TFIP11 CHD1 BIRC6 HMCES ALMS1 CIAPIN1 TNRC6A NAV1 USP1 DPYSL2 ATP13A1 SCAF8 NUCB2 PPHLN1 PAPOLG CDC37 USP14 ZNF106 IARS2 MTMR4	7.59e-10	733	209	22	34672954
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	EMC3 MAP2 PDHB CYTH2 ADGRB1 RPS13 TNRC6B NCAM1 NDUFA9 BIRC6 TENM2 UBA1 KCNQ5 UBE2L3 TNRC6A NAV1 DPYSL2 ATP13A1 CAMK2A RAB11FIP2 ARHGAP39 PPFIA3 OPA1 SHISA9 C1orf198 CNTNAP2 MRPS5	1.42e-09	1139	209	27	36417873
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	NBN CHD1 FANCD2 UBA1 TCERG1 UBE2L3 CIAPIN1 PYGL BOP1 TARS1 CASP8AP2 DPYSL2 SUPT20H RTF2 PPHLN1 PRPF40A CDC37 USP14 NOP58 PRIM1 CCAR1 PHF14 PRKDC SUZ12 TOP2A	2.77e-09	1014	209	25	32416067
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	NUMBL TNRC6B NBN HMCES UBA1 TCERG1 TARS1 SUPT20H RTF2 PRPF40A PAPOLG ZNF106 C1orf198 L3MBTL3 TOP2A	9.39e-08	444	209	15	34795231
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	EMC3 DCAF8 NUMBL MAP2 PDHB PIEZO1 RPS13 NBN PFAS TFIP11 CHD1 NDUFA9 PIK3C2A VPS13A BOP1 TARS1 CASP8AP2 FRAS1 ATP13A1 ESYT1 SYNE1 NUCB2 PRPF40A CDC37 NOP58 IARS2 MRPS5 USP6NL	9.46e-08	1487	209	28	33957083
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	NUMBL PIEZO1 MBD1 TNRC6B NBN TFIP11 CHD1 NDUFA9 TCERG1 PIK3C2A TNRC6A BOP1 FHIP1A SUPT20H RHBDF1 ATP13A1 ARHGAP10 SCAF8 ESYT1 PHF12 SYNE1 PPHLN1 ARHGAP39 CCAR1 MRPS5 PHF14 SUZ12 USP6NL	1.09e-07	1497	209	28	31527615
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	DIS3L2 ARID4B PDHB PFAS CHD1 CCDC178 BIRC6 TMEM106A FANCD2 UBA1 SCAPER USP1 SUPT20H NMNAT1 ATP13A1 PHF12 PPHLN1 FCHO2 PAPOLG USP14 ZNF106 NOP58 SLC12A1 PHF14 SUZ12 SOS1	1.32e-07	1327	209	26	32694731
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	EMC3 NUMBL PDHB NBN PFAS BIRC6 FANCD2 UBA1 VPS13A TNRC6A USP1 UBR2 ARHGAP10 PPP1R11 ARHGAP39 PPFIA3 FCHO2 OPA1 MTMR4 ARVCF PRIM1 L3MBTL3	4.26e-07	1049	209	22	27880917
Pubmed	Magnesium, pH regulation and modulation by mouse ameloblasts exposed to fluoride.	CFTR AMELX AMELY	8.52e-07	4	209	3	27744011
Pubmed	Circadian Rhythm Regulates Development of Enamel in Mouse Mandibular First Molar.	AMELX AMELY MTNR1A	8.52e-07	4	209	3	27494172
Pubmed	Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.	EMC3 PDHB PFAS NDUFA9 UBA1 AGL PYGL ATP13A1 ESYT1 PRPF40A OPA1 NOP58 PRKDC	1.92e-06	422	209	13	27342126
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	DIS3L2 PDHB RPS13 PFAS TFIP11 CHD1 NDUFA9 BIRC6 UBA1 TCERG1 PIK3C2A PYGL BOP1 TARS1 DPYSL2 ESYT1 RTF2 CDC37 USP14 NOP58 ARVCF CCAR1 PRKDC TOP2A	2.38e-06	1353	209	24	29467282
Pubmed	USP1 deubiquitinates Akt to inhibit PI3K-Akt-FoxO signaling in muscle during prolonged starvation.	PDHB CMYA5 USP1 ESYT1 FCHO2	2.78e-06	37	209	5	32133736
Pubmed	Identification of tuftelin- and amelogenin-interacting proteins using the yeast two-hybrid system.	TFIP11 AMELX AMELY	4.22e-06	6	209	3	11063033
Pubmed	Exploring genome-wide - dietary heme iron intake interactions and the risk of type 2 diabetes.	SVEP1 TNRC6A MUSK	4.22e-06	6	209	3	23386860
Pubmed	Ameloblast Modulation and Transport of Cl⁻, Na⁺, and K⁺ during Amelogenesis.	CFTR AMELX AMELY	4.22e-06	6	209	3	26403673
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ARID4B NBN TFIP11 FANCD2 UBA1 SCAF8 PHF12 ARHGAP39 PRPF40A PAPOLG ZNF106 CCAR1 PHF14 PRKDC SUZ12 TOP2A SOS1	5.10e-06	774	209	17	15302935
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	PDHB RPS13 PFAS CHD1 CMYA5 FANCD2 UBA1 TCERG1 BOP1 TARS1 ATP13A1 ESYT1 SYNE1 PRPF40A OPA1 CDC37 NOP58 IARS2 PRIM1 CCAR1 PRKDC SUZ12 TOP2A MYBPC1	5.72e-06	1425	209	24	30948266
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	NUMBL MAP2 PDHB CYTH2 RPS13 NCAM1 ALDH1L1 NDUFA9 SLC12A5 UBA1 C12orf50 SCAPER NAV1 DNAH6 TARS1 DPYSL2 TNC CAMK2A SYNE1 ARHGAP39 PPFIA3 PRPF40A OPA1 ARVCF	6.14e-06	1431	209	24	37142655
Pubmed	Poly (ADP-Ribose) Polymerase 1 Regulates Cajal-Retzius Cell Development and Neural Precursor Cell Adhesion.	NAV1 TNC TBR1	7.36e-06	7	209	3	34708032
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	PDHB RPS13 TFIP11 CHD1 NDUFA9 UBA1 TCERG1 BOP1 ESYT1 PPHLN1 PRPF40A PAPOLG ZNF106 NOP58 CCAR1 MRPS5 PHF14 PRKDC TOP2A	9.46e-06	989	209	19	36424410
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	KLHL41 CMYA5 KMT2E BIRC6 DACT1 ALMS1 PIK3C2A AGL USP1 SKAP2 SYNE1 PPHLN1 MYBPC1	1.12e-05	497	209	13	23414517
Pubmed	A candidate spermatogenesis gene on the mouse Y chromosome is homologous to ubiquitin-activating enzyme E1.	UBA1 AMELX AMELY	1.17e-05	8	209	3	1749428
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DCAF8 NUMBL MAP2 TNRC6B DOCK5 ODF2L UBE2E2 GRK3 KCNQ5 NAV1 UBR2 DPYSL2 FOLH1 ARHGAP10 SCAF8 RTF2 NUCB2 PPHLN1 ARHGAP39 SHISA9 USP14 PCNX4 CCAR1 PHF14	1.18e-05	1489	209	24	28611215
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	DCAF8 ARID4B MBD1 TNRC6B NBN FANCD2 ALMS1 SCAPER TNRC6A SUPT20H ARHGAP10 PHF12 PPFIA3 PRPF40A OPA1 ZFHX4 CCNB3 SUZ12 TOP2A SOS1	1.50e-05	1116	209	20	31753913
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	NUMBL TNRC6B NBN PFAS TFIP11 CHD1 UBA1 ALMS1 TCERG1 CIAPIN1 DPYSL2 ESYT1 PRPF40A CDC37 USP14 IARS2 PRKDC TOP2A	1.57e-05	934	209	18	33916271
Pubmed	Characterization of genes encoding translation initiation factor eIF-2gamma in mouse and human: sex chromosome localization, escape from X-inactivation and evolution.	UBA1 AMELX AMELY	1.75e-05	9	209	3	9736774
Pubmed	Crystal structure of a human ubiquitin E1-ubiquitin complex reveals conserved functional elements essential for activity.	UBA1 UBE2E2 UBE2L3	1.75e-05	9	209	3	30279270
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NUMBL CYTH2 TNRC6B NCAM1 TENM2 SLC12A5 UBA1 NAV1 DPYSL2 CAMK2A SYNE1 ARHGAP39 PPFIA3 OPA1 WDR45 ARVCF CCAR1 CDH11	2.35e-05	963	209	18	28671696
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	RPS13 NBN PFAS BIRC6 HMCES UBA1 GLDC AGL DPYSL2 DHRS4L2 CDC37 USP14 PRKDC	2.36e-05	534	209	13	35032548
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	NUMBL RPS13 TNRC6B UBA1 TCERG1 TARS1 ESYT1 XPNPEP1 ARHGAP39 FCHO2 PRPF40A OPA1 C1orf198 PRKDC USP6NL	2.81e-05	708	209	15	39231216
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TNRC6B NBN TFIP11 UBA1 ALMS1 TCERG1 CIAPIN1 DPYSL2 PRPF40A USP14 NOP58 PRKDC TOP2A	3.15e-05	549	209	13	38280479
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DCAF8 PDHB MBD1 TFIP11 CMYA5 DSCAML1 RYR3 ZNF836 ODF2L TCERG1 TARS1 DPYSL2 SUPT20H FOLH1 ATP13A1 CAMK2A SYNE1 NFE2L3 CCAR1 PRKDC SOS1	3.52e-05	1285	209	21	35914814
Pubmed	Targeting an Achilles' heel of cancer with a WRN helicase inhibitor.	FANCD2 PRKDC	3.59e-05	2	209	2	24036544
Pubmed	Amelogenin, the major protein of tooth enamel: a new phylogenetic marker for ordinal mammal relationships.	AMELX AMELY	3.59e-05	2	209	2	18346915
Pubmed	Molecular cloning and DNA sequence of rat amelogenin and a comparative analysis of mammalian amelogenin protein sequence divergence.	AMELX AMELY	3.59e-05	2	209	2	8297387
Pubmed	The characterization of the first anti-mouse Muc6 antibody shows an increased expression of the mucin in pancreatic tissue of Cftr-knockout mice.	CFTR MUC6	3.59e-05	2	209	2	20309575
Pubmed	Role of GW182 protein in the cell.	TNRC6B TNRC6A	3.59e-05	2	209	2	29791863
Pubmed	Human and mouse amelogenin gene loci are on the sex chromosomes.	AMELX AMELY	3.59e-05	2	209	2	2737677
Pubmed	A solution NMR investigation into the early events of amelogenin nanosphere self-assembly initiated with sodium chloride or calcium chloride.	AMELX AMELY	3.59e-05	2	209	2	19086270
Pubmed	Hierarchical self-assembly of amelogenin and the regulation of biomineralization at the nanoscale.	AMELX AMELY	3.59e-05	2	209	2	21825148
Pubmed	Amelogenin: a potential regulator of cementum-associated genes.	AMELX AMELY	3.59e-05	2	209	2	14653387
Pubmed	A synthetic, chemically modified ribozyme eliminates amelogenin, the major translation product in developing mouse enamel in vivo.	AMELX AMELY	3.59e-05	2	209	2	7489712
Pubmed	Controlled Osteogenic Differentiation of Mouse Mesenchymal Stem Cells by Tetracycline-Controlled Transcriptional Activation of Amelogenin.	AMELX AMELY	3.59e-05	2	209	2	26709694
Pubmed	Comparison of body weight and gene expression in amelogenin null and wild-type mice.	AMELX AMELY	3.59e-05	2	209	2	16674684
Pubmed	Amelogenin-collagen interactions regulate calcium phosphate mineralization in vitro.	AMELX AMELY	3.59e-05	2	209	2	20404336
Pubmed	Identification of the functional activity of the [A-4] amelogenin gene splice product in newborn mouse ameloblasts.	AMELX AMELY	3.59e-05	2	209	2	18394981
Pubmed	A solution NMR investigation into the impaired self-assembly properties of two murine amelogenins containing the point mutations T21→I or P41→T.	AMELX AMELY	3.59e-05	2	209	2	23896516
Pubmed	Genetic variants in ALDH1L1 and GLDC influence the serine-to-glycine ratio in Hispanic children.	ALDH1L1 GLDC	3.59e-05	2	209	2	35460232
Pubmed	Stage-Specific Role of Amelx Activation in Stepwise Ameloblast Induction from Mouse Induced Pluripotent Stem Cells.	AMELX AMELY	3.59e-05	2	209	2	34281250
Pubmed	The X-Y homologous gene amelogenin maps to the short arms of both the X and Y chromosomes and is highly conserved in primates.	AMELX AMELY	3.59e-05	2	209	2	1427830
Pubmed	Transgene animal model for protein expression and accumulation into forming enamel.	AMELX AMELY	3.59e-05	2	209	2	11063035
Pubmed	Regulation of amelogenin gene expression.	AMELX AMELY	3.59e-05	2	209	2	10200911
Pubmed	Cryo-EM reveals a mechanism of USP1 inhibition through a cryptic binding site.	FANCD2 USP1	3.59e-05	2	209	2	36170365
Pubmed	A human X-Y homologous region encodes "amelogenin".	AMELX AMELY	3.59e-05	2	209	2	2004775
Pubmed	Loss of biological control of enamel mineralization in amelogenin-phosphorylation-deficient mice.	AMELX AMELY	3.59e-05	2	209	2	35219810
Pubmed	Of mice and men: anatomy of the amelogenin gene.	AMELX AMELY	3.59e-05	2	209	2	2689082
Pubmed	Alternative transcription initiation and splicing variants of the DHRS4 gene cluster.	DHRS4 DHRS4L2	3.59e-05	2	209	2	18754758
Pubmed	Altering biomineralization by protein design.	AMELX AMELY	3.59e-05	2	209	2	16707492
Pubmed	Mapping of genes and transcribed sequences in a gene rich 400-kb region on human chromosome 11p15.1-->p14.	RPS13 PIK3C2A	3.59e-05	2	209	2	11306805
Pubmed	Amelogenin supramolecular assembly in nanospheres defined by a complex helix-coil-PPII helix 3D-structure.	AMELX AMELY	3.59e-05	2	209	2	21984897
Pubmed	Cryogenic transmission electron microscopy study of amelogenin self-assembly at different pH.	AMELX AMELY	3.59e-05	2	209	2	21597263
Pubmed	Antisense inhibition of AMEL translation demonstrates supramolecular controls for enamel HAP crystal growth during embryonic mouse molar development.	AMELX AMELY	3.59e-05	2	209	2	8392462
Pubmed	An amelogenin mutation leads to disruption of the odontogenic apparatus and aberrant expression of Notch1.	AMELX AMELY	3.59e-05	2	209	2	20923441
Pubmed	Protein interactions during assembly of the enamel organic extracellular matrix.	AMELX AMELY	3.59e-05	2	209	2	9041053
Pubmed	Expression of amelogenin in odontoblasts.	AMELX AMELY	3.59e-05	2	209	2	12667550
Pubmed	Spatial- and temporal-restricted pattern for amelogenin gene expression during mouse molar tooth organogenesis.	AMELX AMELY	3.59e-05	2	209	2	3253061
Pubmed	Isolation and characterization of a pseudoautosomal region-specific genetic marker in C57BL/6 mice using genomic representational difference analysis.	AMELX AMELY	3.59e-05	2	209	2	8618899
Pubmed	Novel LRAP-binding partner revealing the plasminogen activation system as a regulator of cementoblast differentiation and mineral nodule formation in vitro.	AMELX AMELY	3.59e-05	2	209	2	31621902
Pubmed	Leucine rich amelogenin peptide alters ameloblast differentiation in vivo.	AMELX AMELY	3.59e-05	2	209	2	23747796
Pubmed	Alternative splicing of the mouse amelogenin primary RNA transcript contributes to amelogenin heterogeneity.	AMELX AMELY	3.59e-05	2	209	2	1445358
Pubmed	Folding, assembly, and aggregation of recombinant murine amelogenins with T21I and P41T point mutations.	AMELX AMELY	3.59e-05	2	209	2	21540557
Pubmed	Amelogenin in cranio-facial development: the tooth as a model to study the role of amelogenin during embryogenesis.	AMELX AMELY	3.59e-05	2	209	2	19097165
Pubmed	Post-Golgi anterograde transport requires GARP-dependent endosome-to-TGN retrograde transport.	TMEM87A TMEM87B	3.59e-05	2	209	2	26157166
Pubmed	Endoplasmic reticulum stress in amelogenesis imperfecta and phenotypic rescue using 4-phenylbutyrate.	AMELX AMELY	3.59e-05	2	209	2	24362885
Pubmed	Two related low molecular mass polypeptide isoforms of amelogenin have distinct activities in mouse tooth germ differentiation in vitro.	AMELX AMELY	3.59e-05	2	209	2	15647828
Pubmed	DNA sequence for cloned cDNA for murine amelogenin reveal the amino acid sequence for enamel-specific protein.	AMELX AMELY	3.59e-05	2	209	2	4015654
Pubmed	Ubiquitin-Mimicking Peptides Transfer Differentiates by E1 and E2 Enzymes.	UBA1 UBE2L3	3.59e-05	2	209	2	30246024
Pubmed	Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice.	AMELX AMELY	3.59e-05	2	209	2	34780561
Pubmed	Comparison of upstream regions of X- and Y-chromosomal amelogenin genes.	AMELX AMELY	3.59e-05	2	209	2	9714776
Pubmed	Amelogenin phosphorylation regulates tooth enamel formation by stabilizing a transient amorphous mineral precursor.	AMELX AMELY	3.59e-05	2	209	2	31919099
Pubmed	The small bovine amelogenin LRAP fails to rescue the amelogenin null phenotype.	AMELX AMELY	3.59e-05	2	209	2	12958690
Pubmed	[Types and frequencies of variants in Amelogenin gene in Chinese population].	AMELX AMELY	3.59e-05	2	209	2	18067069
Pubmed	The circadian clock modulates enamel development.	AMELX AMELY	3.59e-05	2	209	2	22653892
Pubmed	Interaction of CD5 and CD72 is involved in regulatory T and B cell homeostasis.	CD5 CD72	3.59e-05	2	209	2	24950378
Pubmed	Mouse amelogenin exons 8 and 9: sequence analysis and protein distribution.	AMELX AMELY	3.59e-05	2	209	2	15972588
Pubmed	Amelogenin-deficient mice display an amelogenesis imperfecta phenotype.	AMELX AMELY	3.59e-05	2	209	2	11406633
Pubmed	A giant ubiquitin-conjugating enzyme related to IAP apoptosis inhibitors.	BIRC6 UBE2L3	3.59e-05	2	209	2	9628897
Pubmed	The receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenic pathway is elevated in amelogenin-null mice.	AMELX AMELY	3.59e-05	2	209	2	12851394
Pubmed	Orphan receptor GPR179 forms macromolecular complexes with components of metabotropic signaling cascade in retina ON-bipolar neurons.	GPR179 TRPM1	3.59e-05	2	209	2	24114537
Pubmed	Amelogenin X impacts age-dependent increase of frequency and number in labial incisor grooves in C57BL/6.	AMELX AMELY	3.59e-05	2	209	2	29337060
Pubmed	CDNA cloning of a short isoform of human liver NADP (H) -dependent retinol dehydrogenase/reductase and analysis of its characteristics.	DHRS4 DHRS4L2	3.59e-05	2	209	2	15473316
Pubmed	Thermal denaturation of a recombinant mouse amelogenin: circular dichroism and differential scanning calorimetric studies.	AMELX AMELY	3.59e-05	2	209	2	16284958
Pubmed	The B-cell surface protein CD72/Lyb-2 is the ligand for CD5.	CD5 CD72	3.59e-05	2	209	2	1711157
Pubmed	Molecular structure of the mouse amelogenin genomic DNA.	AMELX AMELY	3.59e-05	2	209	2	8988368
Pubmed	Polypeptides translated from alternatively spliced transcripts of the amelogenin gene, devoid of the exon 6a, b, c region, have specific effects on tooth germ development in culture.	AMELX AMELY	3.59e-05	2	209	2	12489164
Pubmed	The leucine-rich amelogenin protein (LRAP) is primarily monomeric and unstructured in physiological solution.	AMELX AMELY	3.59e-05	2	209	2	25449314
Pubmed	High-yield recombinant bacterial expression of 13 C-, 15 N-labeled, serine-16 phosphorylated, murine amelogenin using a modified third generation genetic code expansion protocol.	AMELX AMELY	3.59e-05	2	209	2	36585836
Pubmed	Isolation and characterization of a mouse amelogenin expressed in Escherichia coli.	AMELX AMELY	3.59e-05	2	209	2	8062146
Pubmed	Transgenic mice that express normal and mutated amelogenins.	AMELX AMELY	3.59e-05	2	209	2	17384027
Cytoband	16p13.12	CPPED1 ERCC4 SHISA9	1.09e-05	10	209	3	16p13.12
GeneFamily	Ubiquitin conjugating enzymes E2	BIRC6 UBE2E2 UBE2L3 UBE2L5	2.17e-04	41	131	4	102
GeneFamily	Ataxins\|Trinucleotide repeat containing	NUMBL TNRC6B TNRC6A	7.61e-04	25	131	3	775
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	SYCP2L ARID4B B3GNT5 MAP2 NBN CHD1 KIF24 FANCD2 ODF2L KCNQ5 ALMS1 TCERG1 UBE2L3 REEP6 VPS13A TRPM1 USP1 CASP8AP2 ZWILCH PPHLN1 PRPF40A PAPOLG NOP58 IARS2 ARVCF PRIM1 CNTNAP2 CCAR1 PHF14 SUZ12 PLEKHO1 TOP2A SOS1	2.64e-06	1459	201	33	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	CHD1 BIRC6 KIF24 FBXO30 ALMS1 TCERG1 REEP6 GLDC USP1 CASP8AP2 PRPF40A OPA1 ZNF106 KDM7A PRKDC SUZ12 PLEKHO1	1.34e-05	532	201	17	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	ARID4B B3GNT5 NBN CHD1 KIF24 FANCD2 ODF2L ALMS1 TCERG1 UBE2L3 REEP6 VPS13A USP1 CASP8AP2 ZWILCH PPHLN1 PRPF40A PAPOLG NOP58 IARS2 PRIM1 CNTNAP2 CCAR1 PHF14 SUZ12 PLEKHO1 TOP2A SOS1	2.19e-05	1257	201	28	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	kidney_P0_CapMes_Crym_top-relative-expression-ranked_100	CFTR NCAM1 DOCK5 HOXD10 TNC CDH11	2.90e-05	63	201	6	gudmap_kidney_P0_CapMes_Crym_100
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	SYCP2L ARID4B B3GNT5 MAP2 CHD1 CHGB DSCAML1 KIF24 FANCD2 ODF2L ALMS1 ADAMDEC1 GLDC VPS13A TRPM1 USP1 CASP8AP2 ZWILCH CAMK2A PPHLN1 TDRD1 PRPF40A PAPOLG IARS2 ARVCF CNTNAP2 CCAR1 PHF14 GALNT6	6.88e-05	1414	201	29	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	NBN ALMS1 REEP6 NAV1 USP1 CASP8AP2 CCAR1 PHF14 SUZ12	7.28e-05	186	201	9	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	KMT2E PMEPA1 REEP6 SCAPER TRPM1 USP1 PRPF40A CCAR1 PHF14 SUZ12	1.24e-04	246	201	10	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3
CoexpressionAtlas	kidney_P1_CapMes_Crym_top-relative-expression-ranked_200	CFTR NCAM1 DOCK5 HOXD10 AGL TNC CDH11	1.48e-04	120	201	7	gudmap_kidney_P1_CapMes_Crym_200
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	CHD1 KLHL41 KIF24 FBXO30 ALMS1 TCERG1 PIK3C2A REEP6 FCHO2 PRPF40A NOP58 CCAR1 PRKDC PLEKHO1	1.61e-04	469	201	14	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	SYCP2L MAP2 CHD1 KMT2E PMEPA1 ALMS1 REEP6 GLDC VPS13A SCAPER TRPM1 USP1 CASP8AP2 LRRC75B TNC PRPF40A OPA1 PAPOLG CNTNAP2 CCAR1 PHF14 SUZ12	1.66e-04	983	201	22	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	kidney_P0_CapMes_Crym_top-relative-expression-ranked_200	CFTR NCAM1 DOCK5 HOXD10 AGL TNC CDH11	1.81e-04	124	201	7	gudmap_kidney_P0_CapMes_Crym_200
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLB1 CFTR DSCAML1 SVEP1 RYR3 DTHD1 FRAS1 SLC12A1 ZFHX4 CNTNAP2	4.68e-09	160	209	10	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLB1 CFTR DSCAML1 SVEP1 RYR3 DTHD1 FRAS1 SLC12A1 ZFHX4 CNTNAP2	4.68e-09	160	209	10	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_C\|368C / Donor, Lineage, Cell class and subclass (all cells)	CCDC30 CYTH2 DOCK5 TBCEL LRRC75B TRGC2 PAPOLG JRK IGLC3	1.06e-07	168	209	9	0372c06b70f0ba95bf8cd1363ca7c5f31207f094
ToppCell	COVID-19_Moderate\|World / disease group, cell group and cell class	ARID4B TNRC6B ODF2L SYNE1 TRGC2 NOP58 CD5 IGLC2 IGLC3	4.44e-07	199	209	9	952fac67588ad5676f5939e3c7f8bac803c27064
ToppCell	COVID-19-Heart-Adipocyte\|Heart / Disease (COVID-19 only), tissue and cell type	PEX11A RYR3 GRK3 KCNQ5 PYGL GPAM ZFHX4 MUSK	1.39e-06	169	209	8	bd39f85b48207955f80ca120a11e15a0124117b9
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS13 RYR3 AEBP1 C6 DNAH6 FRAS1 ZAN CNTNAP2	1.39e-06	169	209	8	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLB1 KLHL41 DSCAML1 IL4I1 RGS3 PAPOLG NFE2L3 MTMR4	1.81e-06	175	209	8	91cb819a1786020713b7e64480de0545380daae9
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHGB DTHD1 IL4I1 SYT13 FRAS1 ZFHX4 CNTNAP2 CD72	1.81e-06	175	209	8	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLB1 KLHL41 DSCAML1 SVEP1 IL4I1 PAPOLG NFE2L3 MTMR4	1.97e-06	177	209	8	4672cc75225a4a23b298afa8ce439628262519db
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-DPB1 ADGRB1 GRK3 NAV1 IL4I1 ARHGAP10 TBR1 PLEKHO1	1.97e-06	177	209	8	70ca5b6fde2e38af1eb88a7d6e8746edba298191
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-DPB1 ADGRB1 GRK3 NAV1 IL4I1 ARHGAP10 TBR1 PLEKHO1	1.97e-06	177	209	8	aa56129d2d5a73a10e33b7162233a4d9337ee535
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs-Migratory_DCs_L.1.2.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-DPB1 ADGRB1 GRK3 NAV1 IL4I1 ARHGAP10 TBR1 PLEKHO1	1.97e-06	177	209	8	d78a6003ce2d15d7771ae385de252eec7e3c3eea
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARID4B GBP7 CHD1 GVINP1 CASP8AP2 SYNE1 FCHO2 TMEM87A	2.06e-06	178	209	8	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFTR DSCAML1 RYR3 SYCP2 FRAS1 ZAN FOLH1 ZFHX4	2.63e-06	184	209	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFTR DSCAML1 RYR3 SYCP2 FRAS1 ZAN FOLH1 ZFHX4	2.63e-06	184	209	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CFTR DSCAML1 RYR3 SYCP2 FRAS1 ZAN FOLH1 ZFHX4	2.63e-06	184	209	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ARID4B BIRC6 ALMS1 PIK3C2A AGL CASP8AP2 PRPF40A SOS1	2.85e-06	186	209	8	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NCAM1 CCDC178 FRAS1 TNC RGS3 ZFHX4 P2RX6 CDH11	3.09e-06	188	209	8	de6f4889e0c5f39fbbaefd85526f645c6afa09d5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SVEP1 AEBP1 JAM3 ARHGAP10 TNC SYNE1 CDH11 MUSK	3.34e-06	190	209	8	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SVEP1 AEBP1 JAM3 ARHGAP10 TNC SYNE1 CDH11 MUSK	3.34e-06	190	209	8	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HLA-DPB1 GRK3 AEBP1 CD72 IGLC2 IGLC3 L3MBTL3 RASGRP2	3.47e-06	191	209	8	a073d58154c801ec499fd969f42b7f1ee7f15d79
ToppCell	Healthy/Control-B_intermediate\|World / Disease group and Cell class	HLA-DPB1 PMEPA1 DSCAML1 AEBP1 CD72 IGLC2 IGLC3 USP6NL	3.61e-06	192	209	8	2266aa695955f5d885708e6bc0d5a8827c306223
ToppCell	Healthy_donor-B_intermediate\|World / disease group, cell group and cell class (v2)	HLA-DPB1 PMEPA1 DSCAML1 AEBP1 CD72 IGLC2 IGLC3 USP6NL	3.61e-06	192	209	8	f77007b284e11f8654ad599eef929df7c6c4ebf0
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	MAP2 SVEP1 FRAS1 TNC RGS3 ZNF106 CDH11 MUSK	3.61e-06	192	209	8	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHGB TENM2 SLC12A5 SYT13 CAMK2A PPFIA3 CNTNAP2 TBR1	3.75e-06	193	209	8	461919ab422bc9d1fcff7a3a4757c75239041d7e
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHGB TENM2 SLC12A5 SYT13 CAMK2A PPFIA3 CNTNAP2 TBR1	3.75e-06	193	209	8	0dd810ad900d3e586551622b2c1de39d76fd6a7f
ToppCell	PBMC-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DPB1 PMEPA1 GLDC CNTNAP2 CD72 IGLC2 IGLC3 USP6NL	3.89e-06	194	209	8	b6328575eedb19e0ad7f4d03041672f3dc146da0
ToppCell	PBMC-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DPB1 PMEPA1 GLDC CNTNAP2 CD72 IGLC2 IGLC3 USP6NL	3.89e-06	194	209	8	b16b96e42ea9734731342d4c41ff1711bd149462
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-immature_B_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	SECISBP2L HLA-DPB1 KMT2E UBE2E2 AEBP1 CD72 IGLC2 IGLC3	4.04e-06	195	209	8	ecaaa3d071e763c40d05d088fbf9e8ca06f78f47
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	KIF24 FANCD2 CASP8AP2 ZWILCH POC1A PRIM1 PRKDC TOP2A	4.20e-06	196	209	8	df366d76ea55f49e349d622effa57c1535df8400
ToppCell	Bronchial-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYCP2L NUMBL TENM2 JAM3 ARHGAP10 WDR45 CDH11 ALPK2	4.36e-06	197	209	8	dfeb4a0eb4dfba90f4a3e6ba31e0ab0e4aba5849
ToppCell	Influenza-Influenza_Severe-Lymphocyte-B-B_intermediate\|Influenza_Severe / Disease, condition lineage and cell class	PMEPA1 ADAMDEC1 JAM3 IFNLR1 AGBL3 CD72 IGLC2 IGLC3	4.53e-06	198	209	8	ab622fee61714471af3a7be0af356e8a484dcaff
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYCP2L TENM2 SVEP1 DACT1 JAM3 ARHGAP10 ZFHX4 CDH11	4.70e-06	199	209	8	3835452e4848d7f7dd8651c17b746b271ef39688
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SYCP2L MAP2 TENM2 SVEP1 DACT1 JAM3 ARHGAP10 CDH11	4.70e-06	199	209	8	9c2db0bb94cba71a3cc1827844da090e213e0258
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ALDH1L1 RYR3 PIK3C2A SYNE1 GPAM ZFHX4 GRAMD2B MYBPC1	4.87e-06	200	209	8	07d942803360e1a1e8e131d6e31c726dd0db1a0b
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_T_activated\|COVID-19_Severe / Disease, condition lineage and cell class	HLA-DPB1 ODF2L DTHD1 ARHGAP10 SYNE1 TRGC2 IGLC2 IGLC3	4.87e-06	200	209	8	b7f80b2db07119069fbf3d245cf1ad79e8648bab
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron\|10w / Sample Type, Dataset, Time_group, and Cell type.	MAP2 RPS13 NCAM1 TENM2 NAV1 ZFHX4 CNTNAP2 CDH11	4.87e-06	200	209	8	f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-B\|COVID-19_Mild / Disease, condition lineage and cell class	HLA-DPB1 PMEPA1 GLDC CNTNAP2 CD72 IGLC2 IGLC3 USP6NL	4.87e-06	200	209	8	11b51dfca161342d92126e0a83d10864348ba3ef
ToppCell	droplet-Liver-HEPATOCYTES-1m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PNPLA1 ADAMDEC1 C6 CASP8AP2 RAB11FIP2 NUCB2 ARHGAP39	8.41e-06	154	209	7	66c93733116e31b65dfb4b0b00de5c39d19cdb84
ToppCell	droplet-Liver-HEPATOCYTES-1m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PNPLA1 ADAMDEC1 C6 CASP8AP2 RAB11FIP2 NUCB2 ARHGAP39	1.08e-05	160	209	7	a494001b1f6dec33624f98fa3c24bad6988d0425
ToppCell	normal_Pleural_Fluid-B_lymphocytes-Undetermined\|normal_Pleural_Fluid / Location, Cell class and cell subclass	HLA-DPB1 TNRC6B KMT2E PTGES3L IGLC2 IGLC3 RASGRP2	1.08e-05	160	209	7	5744cd30709f38e84f7ec8893dc19d7a288b465a
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	B3GNT5 PMEPA1 GRK3 GVINP1 ADAMDEC1 IFNLR1 ALPK2	1.17e-05	162	209	7	93bd29c52846c3156b8b0d2e39c552373efdfe93
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	REEP6 CIAPIN1 BOP1 CAMK2A GPAM C1orf198 SLC12A1	1.22e-05	163	209	7	ce07bc424ef99c547588b07f5c8b39ff0773ca9b
ToppCell	Mild-MAIT\|World / Disease group and Cell class	NDUFA9 IL18RAP IL4I1 FHIP1A TRGC2 PPFIA3 TDRD1	1.27e-05	164	209	7	21dc02997dfae73cf70ce291661928526605dba1
ToppCell	356C-Myeloid-Macrophage-SPP1+_Macrophage_4\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	PLB1 ZXDA SLC12A5 AEBP1 LRRC75B TDRD1 ARVCF	1.37e-05	166	209	7	8d5d09f25e8903d481c2097fed435e69d42ccdb5
ToppCell	IIH-naiveBc\|IIH / Condition, Cell_class and T cell subcluster	MAP2 HLA-DPB1 C12orf50 ADAMDEC1 UBE2L5 IGLC2 IGLC3	1.48e-05	168	209	7	8450ed6720d308c711dfbc76652e5821be7b8e93
ToppCell	IIH-naiveBc-\|IIH / Condition, Cell_class and T cell subcluster	MAP2 HLA-DPB1 C12orf50 ADAMDEC1 UBE2L5 IGLC2 IGLC3	1.48e-05	168	209	7	27b500f79aedc4669988670c92ff1a47dcbdf2a0
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PMEPA1 SVEP1 RYR3 SYCP2 CASP8AP2 PRIM1 CDH11	1.54e-05	169	209	7	16c52a0f6d96ecc1832922fce9b39691849f0d73
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PMEPA1 TENM2 FANCD2 TRPM1 PTGES3L PRIM1 CDH11	1.54e-05	169	209	7	335619507857383c3b0b507cdf05d786ed59e585
ToppCell	Lymphoid-Lymphoid-T_cells_(Cd8+_T_cell)\|Lymphoid / shred on cell class and cell subclass (v4)	GBP7 KIF24 SVEP1 TARS1 TNC ESYT1 AGBL3	1.60e-05	170	209	7	20fd1a312c81c1bf3c5d2d6caf9b578e6b7a4171
ToppCell	URO-Lymphocyte-B-B_intermediate\|URO / Disease, Lineage and Cell Type	HLA-DPB1 GLDC JAM3 CD72 IGLC2 IGLC3 USP6NL	1.60e-05	170	209	7	e11d1510518cedabeece96d4adbb90999e6326fa
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	FANCD2 UBE2E2 IL4I1 NFE2L3 ZNF106 GRAMD2B SUZ12	1.93e-05	175	209	7	334fad1a147de6c007cec5089c02c35cf3220f1b
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-naive_B_cell\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HLA-DPB1 KLHL41 PMEPA1 IFNLR1 CD72 IGLC2 IGLC3	2.07e-05	177	209	7	325c10674b18727ddd50bf088a9c6f4ef29aa809
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_C\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CCDC30 CYTH2 DOCK5 TBCEL LRRC75B PAPOLG JRK	2.15e-05	178	209	7	50bb1f2c6a8d050ff2af217fd76c3b1b7b4a4a69
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-11\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DPB1 DSCAML1 CNTNAP2 CD72 IGLC2 IGLC3 USP6NL	2.15e-05	178	209	7	5d41fede13c8e64b6fdaf2155f1eb72bcfc32fdb
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	MAP2 AEBP1 ARHGAP10 TNC SYNE1 CDH11 ALPK2	2.23e-05	179	209	7	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 NCAM1 POC1A TNC ZFHX4 GALNT6 L3MBTL3	2.31e-05	180	209	7	da723df348d7b8449bb1124f23fe6fa706412adb
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 NCAM1 POC1A TNC ZFHX4 GALNT6 L3MBTL3	2.31e-05	180	209	7	50758b1e7be2e43f83c10ab106900c067e61f5f7
ToppCell	droplet-Heart-nan-3m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 NCAM1 POC1A TNC ZFHX4 GALNT6 L3MBTL3	2.31e-05	180	209	7	5b146a94708b3c3610542a4d0925f3f7a2b19185
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYCP2L CPPED1 PLB1 ZFP69B IL4I1 DPYSL2 PLEKHO1	2.39e-05	181	209	7	1b4eb044825ede6361928442524b1988c8ef58b3
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYCP2L CPPED1 PLB1 ZFP69B IL4I1 DPYSL2 PLEKHO1	2.39e-05	181	209	7	8d7ebbedc373d55e29da02ac2728b4f4118038f2
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-8\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DPB1 PMEPA1 UBE2E2 AEBP1 CD72 IGLC2 IGLC3	2.39e-05	181	209	7	ca34d83daca10c5fa52ecdf4eba7d31b4e7e056e
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PMEPA1 DSCAML1 AEBP1 CD72 IGLC2 IGLC3 USP6NL	2.57e-05	183	209	7	ffa831f67ed005f05d1b80ebc707e046fc08e22f
ToppCell	Control-immature_Neutrophil-\|Control / Disease condition and Cell class	B3GNT5 FANCD2 VPS13A RTF2 NUCB2 RGS3 TOP2A	2.66e-05	184	209	7	c4e8ba82a6aa76c46f05a71d5f1c7926555318cf
ToppCell	Control-Neu_4\|World / 5 Neutrophil clusters in COVID-19 patients	FANCD2 PIK3C2A VPS13A CASP8AP2 RTF2 XPNPEP1 RGS3	2.66e-05	184	209	7	ce7f044956613118ee2e9fb6af2455c3166cb414
ToppCell	Control-immature_Neutrophil\|Control / Disease condition and Cell class	B3GNT5 FANCD2 VPS13A RTF2 NUCB2 RGS3 TOP2A	2.66e-05	184	209	7	2fdae5c6b3eb2232881d933a8c1061fda3623016
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	CCDC30 TSPAN19 DSCAML1 C6 DTHD1 DNAH6 ARHGAP39	2.75e-05	185	209	7	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD8+_T_activated\|COVID-19_Severe / Disease group, lineage and cell class	HLA-DPB1 DTHD1 ARHGAP10 SYNE1 TRGC2 IGLC2 IGLC3	2.95e-05	187	209	7	4c4c4406e16a15dedcd50bbcc2059d722a2e3d2c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DPB1 UBE2E2 GRK3 CD72 IGLC2 IGLC3 USP6NL	3.16e-05	189	209	7	886dceacf96e2b6750c146a381da0bf96a2bb15b
ToppCell	(1)_Osterolineage_cells-(10)_OLC-1\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	PLB1 NCAM1 TNC RGS3 C1orf198 ZFHX4 CDH11	3.16e-05	189	209	7	46c5b975fb9d33017f2d9b7770d45a8bdf95baa2
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DPB1 UBE2E2 GRK3 CD72 IGLC2 IGLC3 USP6NL	3.16e-05	189	209	7	5f1f4321939877374a8ee13de93f2d1390af8e2e
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NCAM1 RYR3 FANCD2 ZFP69B DNAH6 ZFHX4	3.17e-05	128	209	6	2cf0384240a4a663869cf6b27d954236f6214a9a
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DPB1 DTHD1 ARHGAP10 SYNE1 TRGC2 IGLC2 IGLC3	3.27e-05	190	209	7	88c092a5e78ccaddf406f8fff74376bb761b9790
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-Naive_B_cells\|bone_marrow / Manually curated celltypes from each tissue	HLA-DPB1 PMEPA1 CNTNAP2 CD72 IGLC2 IGLC3 USP6NL	3.27e-05	190	209	7	3d45d5011305f13634013d9eeb98f235517dd54e
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DPB1 DTHD1 ARHGAP10 SYNE1 TRGC2 IGLC2 IGLC3	3.27e-05	190	209	7	9501f0995f3d52be90c02b1aa0c7d184bd788c16
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HLA-DPB1 DTHD1 ARHGAP10 SYNE1 TRGC2 IGLC2 IGLC3	3.27e-05	190	209	7	b9182c84e44aa31684b5388cf3ef4fd1b9e51de4
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DPB1 UBE2E2 GRK3 CD72 IGLC2 IGLC3 USP6NL	3.27e-05	190	209	7	60bb6aaea9691d07295f61c14d1650f5041a0f9c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DPB1 DTHD1 ARHGAP10 SYNE1 TRGC2 IGLC2 IGLC3	3.27e-05	190	209	7	4b42a16902d7d1494f953cc88af1e761e76bdf2c
ToppCell	Control-Lymphoid_B\|Control / Disease group, lineage and cell class	HLA-DPB1 PMEPA1 CNTNAP2 CD72 IGLC2 IGLC3 USP6NL	3.38e-05	191	209	7	0a760cd3a48c487ec899adb882fddea8914cfe0c
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NCAM1 KLHL41 TNC RGS3 ZFHX4 CDH11 MYBPC1	3.38e-05	191	209	7	cc9a6a8fad17d6e1a08a68ab7512ae06b1249051
ToppCell	10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	NCAM1 KLHL41 TNC RGS3 ZFHX4 CDH11 MYBPC1	3.38e-05	191	209	7	c16b920ee69ea8536e020ac3475abf1ce972c1e6
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	HLA-DPB1 PMEPA1 CNTNAP2 CD72 IGLC2 IGLC3 USP6NL	3.38e-05	191	209	7	2453064c39b359088d43d52792bf829f83442c82
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ARID4B TNRC6B KMT2E TCERG1 TNRC6A FRAS1 SOS1	3.49e-05	192	209	7	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	356C-Lymphocytic-B_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HLA-DPB1 UBE2E2 GRK3 CNTNAP2 CD72 IGLC2 IGLC3	3.49e-05	192	209	7	f1ac7fa8159f573d140f0e4cbd15256dcb142980
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RPS13 PMEPA1 RYR3 SYT13 TNC TOP2A ALPK2	3.49e-05	192	209	7	b18ae7337eaad1315a5b0ee81c75f7606bd3c7fe
ToppCell	356C-Lymphocytic-B_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HLA-DPB1 UBE2E2 GRK3 CNTNAP2 CD72 IGLC2 IGLC3	3.49e-05	192	209	7	1d7a5d15c76ae45551ce104327a2241fbf7d1827
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-9\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DPB1 PMEPA1 CNTNAP2 CD72 IGLC2 IGLC3 USP6NL	3.61e-05	193	209	7	d5d188a314da1b4c8390276d88173c09dd7ce4bf
ToppCell	background-Cholangiocytes\|background / Sample and Cell Type and Tumor Cluster (all cells)	MAP2 CFTR PMEPA1 SYT13 FRAS1 SHISA9 MUC6	3.61e-05	193	209	7	9152241073dbe02ac2c11d86bec9b5b529196f6e
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	ARID4B TNRC6B KMT2E TCERG1 TNRC6A FRAS1 SOS1	3.61e-05	193	209	7	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	Children_(3_yrs)-Immune-monocyte-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CPPED1 PLB1 HLA-DPB1 GRK3 SKAP2 KDM7A PLEKHO1	3.61e-05	193	209	7	58e1930a1d80ad3729ab9604ac8ebf7308232a3d
ToppCell	Healthy_donor-B_intermediate\|Healthy_donor / disease group, cell group and cell class (v2)	HLA-DPB1 PMEPA1 AEBP1 CD72 IGLC2 IGLC3 USP6NL	3.61e-05	193	209	7	e2be57bf3cbbbbff64853f06b9c11b136f73eea7
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 NCAM1 PMEPA1 RYR3 NOP58 MUSK MYBPC1	3.61e-05	193	209	7	1aa3ab528605dc7b2fec46e759c9d1ee93d59b11
ToppCell	PBMC-Control-Lymphocyte-B\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DPB1 PMEPA1 CNTNAP2 CD72 IGLC2 IGLC3 USP6NL	3.73e-05	194	209	7	a8daf73c186a15adb9ea02793d4bd9cb35c66290
ToppCell	mild-Lymphocytic-B_cells_1\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	HLA-DPB1 RPS13 CNTNAP2 CD72 IGLC2 IGLC3 USP6NL	3.73e-05	194	209	7	fad1986cba9cd23ac68e639d7335fbcd6ae2a4e7
ToppCell	PBMC-Control-Lymphocyte-B\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DPB1 PMEPA1 CNTNAP2 CD72 IGLC2 IGLC3 USP6NL	3.73e-05	194	209	7	39121c7d537ac103f6959271d814fd327be7114f
ToppCell	Control-Lymphoid_B-B_naive\|Control / Disease group, lineage and cell class	HLA-DPB1 PMEPA1 CNTNAP2 CD72 IGLC2 IGLC3 USP6NL	3.73e-05	194	209	7	4f9600960a287cfc020c06b4af3528d4e5797916
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DPB1 PMEPA1 CNTNAP2 CD72 IGLC2 IGLC3 USP6NL	3.73e-05	194	209	7	287439c51528d7bb13bd235875d85631dc91ed91
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-8\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DPB1 PMEPA1 AEBP1 CD72 IGLC2 IGLC3 USP6NL	3.73e-05	194	209	7	e9c907b8ec4329946338cca5ce8e954fa2cec37b
ToppCell	PBMC-Control-Lymphocyte-B-B_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	HLA-DPB1 PMEPA1 CNTNAP2 CD72 IGLC2 IGLC3 USP6NL	3.73e-05	194	209	7	60542304899b99caa38e4abf6b71ba986fa6c399
ToppCell	PBMC-Control-Lymphocyte-B-B_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HLA-DPB1 PMEPA1 CNTNAP2 CD72 IGLC2 IGLC3 USP6NL	3.73e-05	194	209	7	ad9a8cc57f54bdec4cd6990b2cace947b7a163c9
Disease	dietary heme iron intake measurement, type 2 diabetes mellitus	SVEP1 TNRC6A MUSK	5.86e-06	6	198	3	EFO_0008355, MONDO_0005148
Disease	Fanconi anemia (implicated_via_orthology)	ERCC4 FANCD2 USP1	1.63e-05	8	198	3	DOID:13636 (implicated_via_orthology)
Disease	amelogenesis imperfecta type 1E (implicated_via_orthology)	AMELX AMELY	4.48e-05	2	198	2	DOID:0110058 (implicated_via_orthology)
Disease	Colorectal Carcinoma	MAP2 CFTR CHD1 ALDH1L1 DSCAML1 FBXO30 SLC12A5 DACT1 KCNQ5 VPS13A DPYSL2 FOLH1 SYNE1 CCNB3 CCAR1	8.63e-05	702	198	15	C0009402
Disease	focal segmental glomerulosclerosis	CCDC30 ALMS1 DNAH6	1.56e-04	16	198	3	EFO_0004236
Disease	age at menopause	SYCP2L CCDC30 BIRC6 UBE2L3 IL4I1 OPA1 ZFHX4 PRIM1 PRKDC	2.17e-04	302	198	9	EFO_0004704
Disease	autosomal dominant hypocalcemia (biomarker_via_orthology)	AMELX AMELY	2.66e-04	4	198	2	DOID:0090109 (biomarker_via_orthology)
Disease	FANCONI ANEMIA, COMPLEMENTATION GROUP Q	ERCC4 POC1A	2.66e-04	4	198	2	C3808988
Disease	bitter alcoholic beverage consumption measurement	ERCC4 TNRC6B SCAPER TNRC6A DPYSL2 CNTNAP2	2.86e-04	133	198	6	EFO_0010092
Disease	triglyceride measurement, alcohol drinking	PLB1 GPAM NFE2L3 PCIF1 MUSK	5.55e-04	99	198	5	EFO_0004329, EFO_0004530
Disease	autism spectrum disorder (implicated_via_orthology)	CHD1 DSCAML1 CAMK2A ARVCF CNTNAP2 TBR1	5.83e-04	152	198	6	DOID:0060041 (implicated_via_orthology)
Disease	triglyceride measurement, alcohol consumption measurement	PLB1 GPAM NFE2L3 PCIF1 MUSK	6.08e-04	101	198	5	EFO_0004530, EFO_0007878
Disease	response to efavirenz, virologic response measurement	MBD1 PIK3C2A SKAP2 SHISA9	6.29e-04	58	198	4	EFO_0006904, EFO_0006906
Disease	Myasthenia Gravis	HLA-DPB1 MUSK	6.60e-04	6	198	2	C0026896
Disease	acute promyelocytic leukemia (is_marker_for)	NCAM1 KMT2E	6.60e-04	6	198	2	DOID:0060318 (is_marker_for)
Disease	Myasthenia Gravis, Ocular	HLA-DPB1 MUSK	6.60e-04	6	198	2	C0751340
Disease	Myasthenia Gravis, Generalized	HLA-DPB1 MUSK	6.60e-04	6	198	2	C0751339
Disease	phospholipids in HDL measurement	UBE2L3 USP1 GPAM PCIF1	7.61e-04	61	198	4	EFO_0022293
Disease	cortical surface area measurement	MAP2 TNRC6B NCAM1 PMEPA1 TENM2 ZNF891 SVEP1 DACT1 UBE2L3 TNRC6A NAV1 DPYSL2 ZAN ARHGAP39 FCHO2 ZNF106 CCAR1 L3MBTL3 CDH11 SOS1	7.62e-04	1345	198	20	EFO_0010736
Disease	fatty acid measurement	PMEPA1 DSCAML1 USP1 UBR2 GPAM SHISA9 NFE2L3 CD5 PCIF1 MUSK	7.73e-04	436	198	10	EFO_0005110
Disease	HDL cholesterol change measurement, physical activity	UBE2L3 FOLH1 GPAM PCIF1	8.09e-04	62	198	4	EFO_0003940, EFO_0007805
Disease	total lipids in HDL measurement	UBE2L3 USP1 GPAM PCIF1	8.60e-04	63	198	4	EFO_0022307
Disease	low density lipoprotein cholesterol measurement, physical activity	PFAS NFE2L3 CNTNAP2 MUSK	1.02e-03	66	198	4	EFO_0003940, EFO_0004611
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	BIRC6 UBE2L3 USP1 GPAM NFE2L3 PCIF1 L3MBTL3 MUSK	1.07e-03	303	198	8	EFO_0004612, EFO_0020945
Disease	eicosapentaenoic acid measurement	SYCP2L PAPOLG MUSK	1.16e-03	31	198	3	EFO_0007760
Disease	Hepatitis B, Chronic	HLA-DPB1 UBE2L3	1.22e-03	8	198	2	C0524909
Disease	hematocrit	NUMBL PIEZO1 TNRC6B PFAS PNPLA1 UBE2E2 UBE2L3 HOXD10 ZAN ARHGAP10 RGS3 AGBL3 GRAMD2B L3MBTL3 MUSK TDRD12	1.37e-03	1011	198	16	EFO_0004348
Disease	non-alcoholic fatty liver disease	PMEPA1 USP1 GPAM CNTNAP2 L3MBTL3 ALPK2	1.48e-03	182	198	6	EFO_0003095
Disease	C-reactive protein measurement, high density lipoprotein cholesterol measurement	PMEPA1 PCIF1 MUSK	1.53e-03	34	198	3	EFO_0004458, EFO_0004612
Disease	1-palmitoyl-2-oleoyl-GPI (16:0/18:1) measurement	USP1 MUSK	1.56e-03	9	198	2	EFO_0800439
Disease	PITUITARY DWARFISM I	ERCC4 POC1A	1.56e-03	9	198	2	C0342573
Disease	FEV/FEC ratio	DCAF8 MAP2 NCAM1 KCNQ5 SCAPER NAV1 DTHD1 SKAP2 FRAS1 SCAF8 SHISA9 ZNF106 ARVCF CNTNAP2 ERCC6L2 KDM7A SUZ12 L3MBTL3	1.64e-03	1228	198	18	EFO_0004713
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	USP1 GPAM NFE2L3 ZNF106 PCIF1	1.70e-03	127	198	5	EFO_0008595, EFO_0020947
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	PMEPA1 GPAM PCIF1 MUSK	1.90e-03	78	198	4	EFO_0022187
Disease	2-ketocaprylate measurement	ALMS1 PCNX4	1.95e-03	10	198	2	EFO_0800110
Disease	alpha wave measurement, electroencephalogram measurement	CD72 CLUL1	1.95e-03	10	198	2	EFO_0004357, EFO_0006870
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	USP1 GPAM NFE2L3 ZNF106 PCIF1 L3MBTL3 MUSK	2.12e-03	264	198	7	EFO_0008317, EFO_0020944
Disease	Alcoholic Intoxication, Chronic	CFTR NCAM1 DSCAML1 DPYSL2 CAMK2A CNTNAP2 CDH11	2.31e-03	268	198	7	C0001973
Disease	red blood cell density measurement	PIEZO1 TNRC6B DPP8 PNPLA1 UBE2E2 HOXD10 USP1 RAB11FIP2 FCHO2 RGS3 ZNF106 PCIF1 L3MBTL3 MUSK	2.59e-03	880	198	14	EFO_0007978
Disease	Night blindness, congenital stationary, type 1	GPR179 TRPM1	2.83e-03	12	198	2	C3501847
Disease	Night Blindness, Congenital Stationary, Type 1A	GPR179 TRPM1	2.83e-03	12	198	2	C3495587
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder)	GPR179 TRPM1	2.83e-03	12	198	2	C1864877
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B	GPR179 TRPM1	2.83e-03	12	198	2	C1850362
Disease	X-Linked Csnb	GPR179 TRPM1	2.83e-03	12	198	2	C3711543
Disease	NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A	GPR179 TRPM1	2.83e-03	12	198	2	C1848172
Disease	schizophrenia (is_marker_for)	MAP2 NCAM1 OPA1	3.22e-03	44	198	3	DOID:5419 (is_marker_for)
Disease	urate measurement, bone density	PLB1 ERCC4 TENM2 DOCK5 NAV1 SKAP2 CASP8AP2 FRAS1 SYNE1 USP14 PRKDC	3.24e-03	619	198	11	EFO_0003923, EFO_0004531
Disease	Cone-rod synaptic disorder, congenital nonprogressive	GPR179 TRPM1	3.33e-03	13	198	2	C4041558
Disease	level of Phosphatidylinositol (18:1_18:1) in blood serum	USP1 MUSK	3.33e-03	13	198	2	OBA_2045159
Disease	esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement	CFTR DPYSL2	3.33e-03	13	198	2	EFO_0000280, EFO_0000478, EFO_0008343
Disease	Neurodevelopmental Disorders	TNRC6B KMT2E WDR45 TBR1	3.61e-03	93	198	4	C1535926
Disease	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	USP1 NFE2L3 ZNF106 PCIF1 MUSK	3.80e-03	153	198	5	EFO_0004611, EFO_0020946
Disease	gastric ulcer (implicated_via_orthology)	CFTR MUC6	3.87e-03	14	198	2	DOID:10808 (implicated_via_orthology)
Disease	response to methotrexate, aspartate aminotransferase measurement	PLB1 MAP2	3.87e-03	14	198	2	EFO_0004736, GO_0031427
Disease	level of Phosphatidylethanolamine (18:1_18:1) in blood serum	CNTNAP2 MUSK	3.87e-03	14	198	2	OBA_2045142
Disease	heart rate	ERCC4 IFT46 TNRC6A ARHGAP10 L3MBTL3 MUSK	4.24e-03	225	198	6	EFO_0004326
Disease	phospholipids:total lipids ratio	PMEPA1 USP1 GPAM NFE2L3 PCIF1 MUSK	4.43e-03	227	198	6	EFO_0020946
Disease	low density lipoprotein cholesterol measurement, response to selective serotonin reuptake inhibitor	NCAM1 USP6NL	4.44e-03	15	198	2	EFO_0004611, EFO_0005658
Disease	N-acetylmethionine measurement	ALMS1 POC1A	4.44e-03	15	198	2	EFO_0021427
Disease	alcohol consumption measurement, high density lipoprotein cholesterol measurement	UBE2L3 FOLH1 GPAM PCIF1 MUSK	4.83e-03	162	198	5	EFO_0004612, EFO_0007878
Disease	eosinophil percentage of granulocytes	PLB1 HLA-DPB1 CHD1 IL18RAP UBR2 PRKDC	5.12e-03	234	198	6	EFO_0007996
Disease	Hypermetropia	DSCAML1 KCNQ5 ALMS1 ARHGAP10	5.19e-03	103	198	4	HP_0000540
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	CPPED1 UBE2L3 TRGC2 GPAM PCIF1 L3MBTL3 MUSK	5.29e-03	312	198	7	EFO_0004612, EFO_0010351
Disease	lymphocyte percentage of leukocytes	CALR3 NBN IL18RAP DOCK5 UBE2L3 DTHD1 SKAP2 UBR2 ATP13A1 SLC12A1 PRKDC	5.51e-03	665	198	11	EFO_0007993
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	CPPED1 UBE2L3 TRGC2 GPAM PCIF1 L3MBTL3 MUSK	5.57e-03	315	198	7	EFO_0004574, EFO_0004612
Disease	alcohol drinking, high density lipoprotein cholesterol measurement	UBE2L3 FOLH1 GPAM PCIF1 MUSK	5.63e-03	168	198	5	EFO_0004329, EFO_0004612
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	UBE2L3 USP1 GPAM NFE2L3 PCIF1 MUSK	5.67e-03	239	198	6	EFO_0008317, EFO_0020945
Disease	Night blindness, congenital stationary	GPR179 TRPM1	5.70e-03	17	198	2	C0339535
Disease	diastolic blood pressure, systolic blood pressure	CCDC30 MBD1 TNRC6B KMT2E DOCK5 ODF2L ALMS1 NAV1 SKAP2 POC1A PPHLN1	5.81e-03	670	198	11	EFO_0006335, EFO_0006336
Disease	leukemia	KMT2E FANCD2 TOP2A	6.04e-03	55	198	3	C0023418
Disease	phospholipids in medium HDL measurement	UBE2L3 USP1 GPAM	6.04e-03	55	198	3	EFO_0022295
Disease	free cholesterol to total lipids in very large HDL percentage	GPAM PCIF1 MUSK	6.04e-03	55	198	3	EFO_0022288
Disease	basophil percentage of leukocytes	CHD1 DPP8 IL18RAP DTHD1 PRKDC L3MBTL3	6.13e-03	243	198	6	EFO_0007992
Disease	free cholesterol to total lipids in large HDL percentage	SLC12A5 GPAM MUSK	6.35e-03	56	198	3	EFO_0022279
Disease	phosphatidylethanolamine measurement	SYCP2L CMYA5 RYR3 NAV1 MUSK	6.36e-03	173	198	5	EFO_0010228
Disease	serum IgG measurement	PDHB FCHO2	6.39e-03	18	198	2	EFO_0004565
Disease	disease free survival	CCDC168 CNTNAP2	6.39e-03	18	198	2	EFO_0000409

Protein segments in the cluster

Peptide	Gene	Start	Entry
AAQWGELKTSAKEPS	SYT13	271	Q7L8C5
SSAEQWKTIELPVDK	TDRD1	926	Q9BXT4
DSKLVWFDLDLSTKP	BOP1	641	Q14137
LEAWPSTDKTKREEV	AMELX	176	Q99217
IPANWKTELKEDSSS	ARID4B	261	Q4LE39
EAVPEKTWKELRNSE	FAM74A1	51	Q5RGS3
VSFPDVEKAEWLNKI	ESYT1	131	Q9BSJ8
EDIKPLSSKWETASS	AGBL3	931	Q8NEM8
SDPEFVQWKKELNET	GRK3	636	P35626
LEAWPATDKTKQEEV	AMELY	191	Q99218
LEGDAPVSWTETKKQ	CFTR	671	P13569
EDSKPRDAEWTTVFK	ARVCF	506	O00192
TTQEKPKDSDQFEWV	BIRC6	4106	Q9NR09
KKETSPAESKDWEQT	CALR3	206	Q96L12
PAESKDWEQTKDNKA	CALR3	211	Q96L12
DWAKVPEDRVTVSKS	ADGRB1	796	O14514
KVWAVPDSLKADAVV	ALPK2	1271	Q86TB3
EAKEISTPTHWSKLD	CCAR1	621	Q8IX12
DSSPKEETDKWAVEK	AEBP1	346	Q8IUX7
TAVDWTLTKDEKVFP	ATP13A1	596	Q9HD20
TKSQPEKWDEEAQDA	CT47B1	261	P0C2W7
DVKSWEVSDPEEQLK	GVINP1	526	Q7Z2Y8
PVWDVFKTSTEKLAN	FCHO2	71	Q0JRZ9
WFVPVENVESRSKKE	ALMS1	3961	Q8TCU4
RSSKQWEDPSQASKV	CD5	66	P06127
SLDSPVTVEWKAQSD	HLA-DPB1	206	P04440
CLKAPATLTWEDEKQ	CD300LD-AS1	31	Q96MU5
WDKSSPVEALKGLVD	CIAPIN1	16	Q6FI81
DKAAVKSEQPTASWR	CD72	61	P21854
EEVWDKTLDINVKAP	DHRS4	131	Q9BTZ2
WKVVKPESNDKETEA	DIS3L2	121	Q8IYB7
TEKSEWELKTPEKQL	CASP8AP2	1331	Q9UKL3
DQETKRWLKNASPED	CHD1	356	O14646
WESPALKKLSAEASA	ASTL	346	Q6HA08
WEKPSTEKETIFKES	CCNB3	881	Q8WWL7
WAALEGKATVEKPSN	NUMBL	581	Q9Y6R0
EAKLSETISASNAWK	ODF2L	271	Q9ULJ1
RKPSSETDIENWASK	ARHGAP39	686	Q9C0H5
KPTSEEALKWGESLE	RGS3	1061	P49796
PASKVSKWSTDEVSE	L3MBTL3	701	Q96JM7
NSADWEVKTITSALK	ARHGAP10	446	A1A4S6
ASSELELVNSWKESP	MUC6	1021	Q6W4X9
KLQEVDSLWKEFETP	NOP58	21	Q9Y2X3
SPWNSEDAKGLIKSA	PDHB	176	P11177
VSASDDKTVKLWDKS	POC1A	161	Q8NBT0
EEVWDKTLDINVKAP	DHRS4L2	131	Q6PKH6
LEWEVSVPEAKSIKS	IL18RAP	296	O95256
KTEDPDLRTSSWIKQ	KDM7A	796	Q6ZMT4
QDSLLADATIWKPDS	FRAS1	31	Q86XX4
PATQQTRWKKDLAED	IFNLR1	311	Q8IU57
VLEEWTSAAKPKLDQ	RASGRP2	406	Q7LDG7
AQEAATSEKAKICPW	GPR179	1806	Q6PRD1
IWDPDSVKTISAKTH	DPYSL2	411	Q16555
TATTKPETKEISWEQ	PPFIA3	931	O75145
DITAEGSPTKVQKSW	KCNQ5	451	Q9NR82
ALFDIESKVDPSKAW	FOLH1	711	Q04609
DVKIWTPTAKAATEL	DCAF8L2	536	P0C7V8
KDLKEDWSVTTPVKE	CCDC178	131	Q5BJE1
PTRKEEEASFWKINA	C1orf198	181	Q9H425
PQVKQEKADTQDEWT	MBD1	496	Q9UIS9
WSDDNIFDDEPTIKK	PCNX4	821	Q63HM2
VVWSSEKTPKADQDG	JRK	461	O75564
LQVSPKSEDISKFDW	PIK3C2A	256	O00443
EEKNVSSLLAKDPWD	PIK3C2A	291	O00443
DVKIWAPTAEASTEL	DCAF8	501	Q5TAQ9
NKIAEKPDWEAEKTT	NFE2L3	231	Q9Y4A8
PSDWIQKTATSETAK	LRRC31	46	Q6UY01
ESPAEDSNWVNKVFK	PNPLA1	491	Q8N8W4
KDLTKSWVDSRDPIN	KIF24	886	Q5T7B8
ESKEFAPTEVNDIWK	KLHL41	556	O60662
NEWLSEKNEKTGKPS	KMT2E	736	Q8IZD2
AIKDTTKFPALAWVD	LRRC75B	231	Q2VPJ9
KSDPKSDSWIFALAV	GBP7	106	Q8N8V2
TDSQTSDPRIEWKKI	JAM3	56	Q9BX67
ATEKKEFLEPDSWET	NUCB2	321	P80303
WLSAEIEDVKPAKTV	NDUFA9	361	Q16795
TATEEQVSEPKKWNL	PHF14	171	O94880
PWNQSDESSRSQEKK	MAGEA13P	81	A6NCF6
ASWEPVDKKETEVTR	MTMR4	1096	Q9NYA4
IAPLESAAIWSKEKD	PMEPA1	266	Q969W9
TETKQSTWEKPDDLK	PRPF40A	161	O75400
NKESWDKILALVPET	PRIM1	236	P49642
KPEKKVEWTSDTVDN	PPP1R11	36	O60927
TDKQLPNKAVEVAWE	OPA1	661	O60313
QKEVVLDSWPDFKAV	GLYATL3	41	Q5SZD4
VKEWISDVSESKNLP	PAPOLG	71	Q9BWT3
IKAIESPSKDDDTVW	REEP6	71	Q96HR9
DLWKNATDPKVKTIS	B3GNT5	331	Q9BYG0
SADVIQKWITEEKPE	DNAH6	476	Q9C0G6
LAPRKDKSQTELEWD	FHIP1A	566	Q05DH4
DAEKNPKAIDTWIES	IFT46	171	Q9NQC8
PKQWSKESKAEQAES	DACT1	416	Q9NYF0
PDSRKVVKWNVEDTF	PCIF1	306	Q9H4Z3
DWSLSKSQVIAEKAP	DOCK5	1736	Q9H7D0
EKTFSEWLESVKENP	C6	466	P13671
LWVPNSKASEAKEGE	CDC37	341	Q16543
VKWTKDSEDSAIPVS	DSCAML1	1321	Q8TD84
QKSKWTPLETQEKEE	GALNT6	121	Q8NCL4
WSEAEKEIKFDSLPS	CMYA5	1436	Q8N3K9
LEKANTELSWPSKED	CMYA5	2021	Q8N3K9
TELSWPSKEDSQEKI	CMYA5	2026	Q8N3K9
EDDPTCKTKEFWATI	DPP8	606	Q6V1X1
GAVTVAWKADSSPVK	IGLC2	36	P0DOY2
AWKADSSPVKAGVET	IGLC2	41	P0DOY2
ISAPTQEEKDEWIKS	CYTH2	356	Q99418
GAVTVAWKADSSPVK	IGLC3	36	P0DOY3
AWKADSSPVKAGVET	IGLC3	41	P0DOY3
ESKEEIKSDTPTSNW	HOXD10	246	P28358
ESVPEATEKWKHSEQ	CCDC30	676	Q5VVM6
KTTKPLDREETAWLN	CDH11	441	P55287
RTLAAFPAEKESEWK	CPPED1	16	Q9BRF8
TKRVSKDPVEALWDN	DTHD1	666	Q6ZMT9
GTSVSQKVCEWKEPE	CSAD	36	Q9Y600
PNFTETIDESKKEWL	CNTNAP2	1316	Q9UHC6
KSTSKEPVDFEQWIE	HSPB11	76	Q9Y547
PADTNKAFKTEWEAL	EMC3	211	Q9P0I2
QEDKEVEIWSKPFAS	CCDC168	3961	Q8NDH2
REEPATSLWKSNEKF	ERCC6L2	1526	Q5T890
LSKSDNWKVTVDPAE	FAM217A	266	Q8IXS0
ADSPDQKKIISLWSK	GRAMD2B	56	Q96HH9
CWSKPKEDKAVDTSD	FBXO30	396	Q8TB52
NTEWETVKSSEPVKE	SCAF8	596	Q9UPN6
DAQSRPTSLAWEVKK	SCAPER	161	Q9BY12
DIQGPTKADTEKWAE	CHGB	111	P05060
WAAEKLEKSDESNLP	PPHLN1	236	Q8NEY8
SKTPQKEESDVPQWS	HMCES	301	Q96FZ2
VWPSGDKEKSNISND	FANCD2	1166	Q9BXW9
WKSCPETDAEKLVQL	CROT	581	Q9UKG9
EAKAPKATANSVWRE	P2RX6	376	O15547
ETDPEKVHLTWTKDK	SLC12A5	1021	Q9H2X9
SQDWKAERSQDPFEK	IL4I1	21	Q96RQ9
EAVPEKTWKELRNSE	FAM74A4	51	Q5TZK3
SWFSESEEKAPKKLE	NAV1	471	Q8NEY1
KVSQPSAEVWNENKE	GARIN3	416	Q8TC56
KNVTELKLSDNPAWE	RTF2	86	Q9BY42
VPDVKLDWEDVKTAQ	MRPS5	401	P82675
TLPDGKQVDAESWKT	TARS1	86	P26639
WREDENKSILSSKPA	TMEM106A	11	Q96A25
AEDAKPKDLSDSSWI	TBR1	601	Q16650
KFSWLTVPEESLDKE	TRGC2	71	P03986
DEWLKTAEEKVSPRT	SYNE1	3611	Q8NF91
QADTWDLSERPKEIK	NBN	371	O60934
AASPKDAEEWVQQLK	SKAP2	201	O75563
RDSTDIVPAKKWDNA	TDRD12	141	Q587J7
DISPSLAEQQWDKKL	GPAM	666	Q9HCL2
WDSEQTEKADIKPVI	PHF12	456	Q96QT6
FESPSEAALKDWEKA	RHBDF1	281	Q96CC6
DGDWAVSTLKSPKAD	SHISA9	286	B4DS77
ETPWKITDAELEAVK	SLC12A1	1016	Q13621
VKPDDLEWASQQSTE	SECISBP2L	946	Q93073
KVPWSLKNSSIDSGE	TENM2	436	Q9NT68
SPKFSEISVLIWDDA	WDR45	71	Q9Y484
TSSIWKKPGLEEAVE	IARS2	866	Q9NSE4
KEKSASQDPLWFSVA	PEX11A	156	O75192
EWDTVTPEAKDLINK	CAMK2A	236	Q9UQM7
NSPDINLEKDWKLVT	PLB1	1191	Q6P1J6
PSELVGSVWTKEDKE	SOS1	801	Q07889
GSVWTKEDKEINSPN	SOS1	806	Q07889
AVAKTWENTKESPAT	SVEP1	2656	Q4LDE5
SPEEKESWINALNSA	PLEKHO1	116	Q53GL0
WSDGDKIKVVPSAST	ADAMDEC1	271	O15204
KETAKINWDQPAEAI	ALDH1L1	206	O75891
NDASSLWTKTPEEIE	C12orf50	96	Q8NA57
APTWKDKTAISENLK	CLUL1	21	Q15846
EEKASWTRPEKQETL	NCAM1	351	P13591
TKEPLEVSEWNKNSS	ZFHX4	1306	Q86UP3
KWNKPSDVSATERTA	USP6NL	486	Q92738
KIKTVWQLSDSSPID	ZWILCH	541	Q9H900
DLSPREKVWVSDKAS	XPNPEP1	281	Q9NQW7
PEETASSTAHLWEKK	VPS13A	1676	Q96RL7
DILKDNWSPALTISK	UBE2E2	141	Q96LR5
QSRWSKVKDKVESDP	TCERG1	811	O14776
SAENWKPATKTDQVI	UBE2L5	91	A0A1B0GUS4
PVEETKAEAASLVSW	RYR3	4586	Q15413
SVPTWLKLTSDDVKE	RPS13	21	P62277
AENTLWDSVTLPKEA	SYCP2L	336	Q5T4T6
KNTENAKQSDWPVES	SYCP2	706	Q9BX26
WTGETNDKSTAPIAK	SUZ12	361	Q15022
WTAEALPSAEETKKL	PFAS	46	O15067
SKPALISWVEEKAEL	ZNF747	81	Q9BV97
KSIKSDDSQPTVWPA	SUPT20H	316	Q8NEM7
KSIKETSVEVEWDPL	TNC	721	P24821
VAEKTLEPVWKEEAS	RAB11FIP2	51	Q7L804
PWDVTKLKSDTAAAA	UBA1	521	P22314
TEAKKDEWGLVAPIS	MAP2	271	P11137
KDWSNDVRAELAKTP	PRKDC	3586	P78527
SWLQPEKHSKDEIIS	ZSCAN4	71	Q8NAM6
ESKQVETQPEKWSVA	TRPM1	31	Q7Z4N2
KPLWQEIFISDADKT	ZNF658	96	Q5TYW1
KSPSDLWKEDLATFI	TOP2A	1161	P11388
KPATSENFDEDLKWV	TMEM87B	501	Q96K49
ENSVSELLTPAKAEW	ZXDA	741	P98168
TKTKESALQNDISWE	ZFP69B	151	Q9UJL9
EKLLKWAESPAALTE	PIEZO1	536	Q92508
ESNPKWEALTEVLKE	ERCC4	376	Q92889
AKVNSKPVWLSVDFD	PTGES3L	101	E9PB15
EWIKFDDDKVSIVTP	USP14	446	P54578
ISKPTEWSDELRQKF	UBR2	486	Q8IWV8
WNVEPSDLKISLSNE	PYGL	826	P06737
SKDKPEDITKWTILN	TSPAN19	131	P0C672
EKPDSPSKKDIWNST	ZNF106	1446	Q9H2Y7
SWEDIDKLNSFPKLE	TBCEL	241	Q5QJ74
KNAVVSDLSEKEAWP	TNRC6A	226	Q8NDV7
EEFQKELSQWRKDPS	TFIP11	216	Q9UBB9
TKESTVQKILWEEPS	ZNF891	121	A8MT65
KLSLEEWSTKPTNDS	USP1	561	O94782
DDLKWVEENVPSSVT	TMEM87A	516	Q8NBN3
EFSQEEWKSLDPVQK	ZNF836	16	Q6ZNA1
GELSASTEWKDPKNT	TNRC6B	681	Q9UPQ9
SAENWKPATKTDQVI	UBE2L3	91	P68036
DSEFVNSWKDKDIDP	ZAN	2091	Q9Y493
KLNSSSELAPITWKE	GLDC	561	P23378
VVAPELFTTEKAWKA	AGL	1386	P35573
VDSSNDVADRVKWKP	MTNR1A	321	P48039
KAAATISIAEWSKPQ	MUSK	296	O15146
KEAGTTPAKDWTLVE	MYBPC1	26	Q00872
ESFAVPNLWKSEDIT	NMNAT1	161	Q9HAN9